Literature DB >> 27175267

Adoptive immunotherapy for myeloid malignancies.

J L Reagan1.   

Abstract

Entities:  

Keywords:  allo-SCT; cellular infusion; cytokine release syndrome; halpoidentical peripheral blood stem cells; minimal conditioning

Year:  2014        PMID： 27175267      PMCID： PMC4851276          DOI： 10.1038/leusup.2014.12

Source DB:  PubMed          Journal:  Leuk Suppl        ISSN： 2044-5210


× No keyword cloud information.
  9 in total

1.  Mechanisms of the antitumor responses and host-versus-graft reactions induced by recipient leukocyte infusions in mixed chimeras prepared with nonmyeloablative conditioning: a critical role for recipient CD4+ T cells and recipient leukocyte infusion-derived IFN-gamma-producing CD8+ T cells.

Authors:  Marie-Therese Rubio; Toshiki I Saito; Kristin Kattleman; Guiling Zhao; Jennifer Buchli; Megan Sykes
Journal:  J Immunol       Date:  2005-07-15       Impact factor: 5.422

2.  Infusion of HLA-mismatched peripheral blood stem cells improves the outcome of chemotherapy for acute myeloid leukemia in elderly patients.

Authors:  Mei Guo; Kai-Xun Hu; Chang-Lin Yu; Qi-Yun Sun; Jian-Hui Qiao; Dan-Hong Wang; Guang-Xian Liu; Wan-Jun Sun; Li Wei; Xue-Dong Sun; Ya-Jing Huang; Jun-Xiao Qiao; Zheng Dong; Hui-Sheng Ai
Journal:  Blood       Date:  2010-10-21       Impact factor: 22.113

3.  Invariant NKT cells are required for antitumor responses induced by host-versus-graft responses.

Authors:  Toshiki I Saito; Hao Wei Li; Megan Sykes
Journal:  J Immunol       Date:  2010-07-14       Impact factor: 5.422

4.  Nonengraftment haploidentical cellular immunotherapy for refractory malignancies: tumor responses without chimerism.

Authors:  Gerald A Colvin; David Berz; Muthalagu Ramanathan; Eric S Winer; Loren Fast; Gerald J Elfenbein; Peter J Quesenberry
Journal:  Biol Blood Marrow Transplant       Date:  2009-04       Impact factor: 5.742

5.  HLA-mismatched stem-cell microtransplantation as postremission therapy for acute myeloid leukemia: long-term follow-up.

Authors:  Mei Guo; Kai-Xun Hu; Guang-Xian Liu; Chang-Lin Yu; Jian-Hui Qiao; Qi-Yun Sun; Jun-Xiao Qiao; Zheng Dong; Wan-Jun Sun; Xue-Dong Sun; Hong-Li Zuo; Qiu-Hong Man; Zhi-Qing Liu; Tie-Qiang Liu; Hong-Xia Zhao; Ya-Jing Huang; Li Wei; Bing Liu; Juan Wang; Xu-Liang Shen; Hui-Sheng Ai
Journal:  J Clin Oncol       Date:  2012-10-08       Impact factor: 44.544

6.  Low-dose total body irradiation followed by allogeneic lymphocyte infusion may induce remission in patients with refractory hematologic malignancy.

Authors:  Karen K Ballen; Pamela S Becker; Robert V B Emmons; Thomas J Fitzgerald; Chung C Hsieh; Qin Liu; Christine Heyes; Yeteive Clark; William Levy; Jean Francois Lambert; Frank Chiafari; Irma Szymanski; Sarah Rososhansky; Mark A Popovsky; F Marc Stewart; Peter J Quesenberry
Journal:  Blood       Date:  2002-07-15       Impact factor: 22.113

7.  The allogeneic effect revisited: exogenous help for endogenous, tumor-specific T cells.

Authors:  Heather J Symons; Moshe Y Levy; Jie Wang; Xiaotao Zhou; Gang Zhou; Sarah E Cohen; Leo Luznik; Hyam I Levitsky; Ephraim J Fuchs
Journal:  Biol Blood Marrow Transplant       Date:  2008-05       Impact factor: 5.742

8.  Antitumor effect of donor marrow graft rejection induced by recipient leukocyte infusions in mixed chimeras prepared with nonmyeloablative conditioning: critical role for recipient-derived IFN-gamma.

Authors:  Marie-Therese Rubio; Yong-Mi Kim; Teviah Sachs; Markus Mapara; Guiling Zhao; Megan Sykes
Journal:  Blood       Date:  2003-06-05       Impact factor: 22.113

9.  Cellular immunotherapy for refractory hematological malignancies.

Authors:  John L Reagan; Loren D Fast; Howard Safran; Martha Nevola; Eric S Winer; Jorge J Castillo; James N Butera; Matthew I Quesenberry; Carolyn T Young; Peter J Quesenberry
Journal:  J Transl Med       Date:  2013-06-19       Impact factor: 5.531
  9 in total
  1 in total

1.  Cooperation of CD4+ T cells and CD8+ T cells and release of IFN-γ are critical for antileukemia responses of recipient mice treated by microtransplantation.

Authors:  Li Wang; Fan Du; Hongxiang Wang; Conghua Xie
Journal:  Exp Ther Med       Date:  2017-11-22       Impact factor: 2.447
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.